chr16-9763583-C-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2
The ENST00000330684.4(GRIN2A):āc.3961G>Cā(p.Glu1321Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,613,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
ENST00000330684.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRIN2A | NM_001134407.3 | c.3961G>C | p.Glu1321Gln | missense_variant | 13/13 | ENST00000330684.4 | NP_001127879.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRIN2A | ENST00000330684.4 | c.3961G>C | p.Glu1321Gln | missense_variant | 13/13 | 1 | NM_001134407.3 | ENSP00000332549 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000399 AC: 10AN: 250932Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135654
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461584Hom.: 0 Cov.: 33 AF XY: 0.00000550 AC XY: 4AN XY: 727122
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74418
ClinVar
Submissions by phenotype
Landau-Kleffner syndrome Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | May 19, 2020 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 12, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | New York Genome Center | Jul 22, 2019 | The c.3961G>C (p.Glu1321Gln) variant identified in the GRIN2A gene substitutes a conserved Glutamic acid for Glutamine at amino acid 1321/1465 (coding exon 13/13). This variant is identified in gnomAD (10 heterozygotes, 0 homozygoutes; allele frequency:3.985e-5), and ExAC (6 heterozygotes, 0 homozygotes; allele frequency: 4.956e-5). In silico algorithms predict this variant to be Neutral (Proven; score: -0.90) and Tolerated (SIFT; score: 0.244) to the function of the canonical transcript. This variant is reported as a Variant of Uncertain Significance in ClinVar (VarID: 205681; 2 stars), and to our current knowledge has not been reported in affected individuals in the literature. The p.Glu1321 residue is within the C-terminal domain of GRIN2A, which is involved in signal mediation [PMID: 30544257], however the C-terminal domain is not associated with an increased burden of pathogenic variants, and benign missense variants within this domain are found in healthy individuals in population databases. Given the lack of compelling evidence for the pathogenicity of this variant, the c.3961G>C (p.Glu1321Gln) variant is reported here as a Variant of Uncertain Significance.AS34 - |
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 27, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 18, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at